A Translational Model for Antidepressant Efficacy Evaluation in Postpartum Depression Research

In this case study, Ace Therapeutics utilized a hormone withdrawal-induced rat model of postpartum depression (PPD) to evaluate the antidepressant potential of a test compound. This model recapitulates key hormonal fluctuations associated with pregnancy and postpartum transition, providing a translational platform for evaluating candidate therapeutics targeting PPD-related behavioral phenotypes.

Model Establishment Strategy

The model is established through:

1. Ovariectomy
2. Hormonal priming with estradiol and progesterone
3. Hormone withdrawal
4. Induction of PPD-like behavioral phenotypes

Key Behavioral Assessments

Sucrose Preference Test (SPT):

• Assesses anhedonia-like behavior through changes in sucrose preference
• Evaluates antidepressant-like effects following treatment

Forced Swim Test (FST):

• Measures despair-like behavioral responses
• Supports antidepressant efficacy evaluation

Study Highlights

• Female SD rats with hormone withdrawal-induced PPD-like behaviors were treated with an oral test compound.
• Increased sucrose preference in the SPT suggested improved anhedonia-like behavior.
• Reduced immobility time in the FST supported antidepressant-like behavioral effects.
• Dose-dependent improvements were observed following treatment.

Download This Case Study to Explore

• Experimental design and hormone withdrawal modeling timeline
• Behavioral assessment workflow and evaluation endpoints
• Representative efficacy data from SPT and FST
• Application of PPD models in antidepressant drug discovery

Interested in evaluating your candidate compounds in postpartum depression models? Contact Ace Therapeutics for customized preclinical study solutions.

You might be interested in...